Clorox Co (CLX) Position Raised by Benjamin F. Edwards & Company Inc.

Benjamin F. Edwards & Company Inc. boosted its position in shares of Clorox Co (NYSE:CLX) by 15.8% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 13,082 shares of the company’s stock after buying an additional 1,784 shares during the quarter. Benjamin F. Edwards & Company Inc.’s holdings in Clorox were worth $1,946,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of CLX. CIBC World Markets Inc. raised its holdings in Clorox by 39.7% during the 2nd quarter. CIBC World Markets Inc. now owns 3,801 shares of the company’s stock valued at $506,000 after buying an additional 1,081 shares during the last quarter. Franklin Resources Inc. raised its holdings in Clorox by 16.9% during the 2nd quarter. Franklin Resources Inc. now owns 32,052 shares of the company’s stock valued at $4,270,000 after buying an additional 4,640 shares during the last quarter. Profund Advisors LLC raised its holdings in Clorox by 26.5% during the 2nd quarter. Profund Advisors LLC now owns 3,763 shares of the company’s stock valued at $501,000 after buying an additional 789 shares during the last quarter. Westfield Capital Management Co. LP bought a new stake in Clorox during the 2nd quarter valued at $4,899,000. Finally, UBS Asset Management Americas Inc. raised its holdings in Clorox by 2.3% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 489,348 shares of the company’s stock valued at $65,201,000 after buying an additional 10,946 shares during the last quarter. Institutional investors own 73.27% of the company’s stock.

Clorox Co (NYSE CLX) opened at $144.32 on Thursday. The company has a debt-to-equity ratio of 3.02, a current ratio of 1.10 and a quick ratio of 0.77. Clorox Co has a 1-year low of $118.87 and a 1-year high of $150.40. The company has a market cap of $18,610.00, a price-to-earnings ratio of 26.48, a price-to-earnings-growth ratio of 3.69 and a beta of 0.42.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Wednesday, November 1st. The company reported $1.46 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.41 by $0.05. The company had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.48 billion. Clorox had a net margin of 11.84% and a return on equity of 161.59%. Clorox’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same period last year, the business earned $1.36 EPS. sell-side analysts predict that Clorox Co will post 5.7 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be paid a $0.84 dividend. The ex-dividend date is Tuesday, January 23rd. This represents a $3.36 annualized dividend and a dividend yield of 2.33%. Clorox’s payout ratio is 61.65%.

A number of equities research analysts recently commented on the stock. Wells Fargo & Co reiterated a “hold” rating and set a $130.00 price target on shares of Clorox in a report on Wednesday, December 13th. Bank of America upgraded shares of Clorox from an “underperform” rating to a “neutral” rating and set a $155.00 price objective for the company in a report on Thursday, January 4th. Consumer Edge upgraded shares of Clorox from a “neutral” rating to an “outperform” rating in a report on Friday, November 10th. Jefferies Group restated a “hold” rating and issued a $130.00 price objective on shares of Clorox in a report on Wednesday, December 13th. Finally, Deutsche Bank initiated coverage on shares of Clorox in a report on Wednesday, December 13th. They issued a “hold” rating and a $142.00 price objective for the company. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $134.33.

In related news, SVP Matthew T. Laszlo sold 20,051 shares of the stock in a transaction dated Wednesday, November 8th. The shares were sold at an average price of $130.46, for a total value of $2,615,853.46. Following the completion of the transaction, the senior vice president now directly owns 10,896 shares in the company, valued at approximately $1,421,492.16. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Michael R. Costello sold 10,574 shares of the stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the completion of the transaction, the senior vice president now owns 34,867 shares of the company’s stock, valued at $4,742,260.67. The disclosure for this sale can be found here. 1.00% of the stock is owned by company insiders.

ILLEGAL ACTIVITY WARNING: This report was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://stocknewstimes.com/2018/01/18/clorox-co-clx-position-raised-by-benjamin-f-edwards-company-inc.html.

Clorox Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply